Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
133,765,508
-
Total 13F shares
-
9,944,716
-
Share change
-
-273,758
-
Total reported value
-
$29,711,425
-
Put/Call ratio
-
0%
-
Price per share
-
$2.99
-
Number of holders
-
19
-
Value change
-
-$816,969
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q1 2023
As of 31 Mar 2023,
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,944,716 shares.
The largest 10 holders included
Oasis Management Co Ltd., Man Group plc, BlueCrest Capital Management Ltd, NATIXIS ADVISORS, L.P., BANK OF AMERICA CORP /DE/, MORGAN STANLEY, NORTHERN TRUST CORP, MONETA GROUP INVESTMENT ADVISORS LLC, AMERICAN CENTURY COMPANIES INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.